Literature DB >> 29312672

Targeted temperature management after cardiac arrest: when, how deep, how long?

Samuel A Tisherman1.   

Abstract

Entities:  

Year:  2017        PMID： 29312672      PMCID： PMC5757006          DOI： 10.21037/jtd.2017.11.20

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.

Authors: 
Journal:  N Engl J Med       Date:  1991-05-02       Impact factor: 91.245

2.  European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015.

Authors:  Jerry P Nolan; Jasmeet Soar; Alain Cariou; Tobias Cronberg; Véronique R M Moulaert; Charles D Deakin; Bernd W Bottiger; Hans Friberg; Kjetil Sunde; Claudio Sandroni
Journal:  Resuscitation       Date:  2015-10       Impact factor: 5.262

3.  Targeted Temperature Management After Cardiac Arrest: Finding the Right Dose for Critical Care Interventions.

Authors:  Clifton W Callaway
Journal:  JAMA       Date:  2017-07-25       Impact factor: 56.272

Review 4.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

5.  Impact of therapeutic hypothermia onset and duration on survival, neurologic function, and neurodegeneration after cardiac arrest.

Authors:  Dongfang Che; Luchuan Li; Catherine M Kopil; Ziyue Liu; Wensheng Guo; Robert W Neumar
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

Review 6.  Therapeutic hypothermia: benefits, mechanisms and potential clinical applications in neurological, cardiac and kidney injury.

Authors:  Elizabeth M Moore; Alistair D Nichol; Stephen A Bernard; Rinaldo Bellomo
Journal:  Injury       Date:  2011-04-09       Impact factor: 2.586

7.  Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.

Authors:  Hans Kirkegaard; Eldar Søreide; Inge de Haas; Ville Pettilä; Fabio Silvio Taccone; Urmet Arus; Christian Storm; Christian Hassager; Jørgen Feldbæk Nielsen; Christina Ankjær Sørensen; Susanne Ilkjær; Anni Nørgaard Jeppesen; Anders Morten Grejs; Christophe Henri Valdemar Duez; Jakob Hjort; Alf Inge Larsen; Valdo Toome; Marjaana Tiainen; Johanna Hästbacka; Timo Laitio; Markus B Skrifvars
Journal:  JAMA       Date:  2017-07-25       Impact factor: 56.272

8.  Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study.

Authors:  K Kuboyama; P Safar; A Radovsky; S A Tisherman; S W Stezoski; H Alexander
Journal:  Crit Care Med       Date:  1993-09       Impact factor: 7.598

9.  Beneficial effect of mild hypothermia and detrimental effect of deep hypothermia after cardiac arrest in dogs.

Authors:  V Weinrauch; P Safar; S Tisherman; K Kuboyama; A Radovsky
Journal:  Stroke       Date:  1992-10       Impact factor: 7.914

10.  Relationship between time to target temperature and outcome in patients treated with therapeutic hypothermia after cardiac arrest.

Authors:  Moritz Haugk; Christoph Testori; Fritz Sterz; Maximilian Uranitsch; Michael Holzer; Wilhelm Behringer; Harald Herkner
Journal:  Crit Care       Date:  2011-03-25       Impact factor: 9.097
View more
  1 in total

1.  Prolonged targeted temperature management in patients suffering from out-of-hospital cardiac arrest.

Authors:  Hans Kirkegaard; Fabio Silvio Taccone; Markus B Skrifvars; Eldar Søreide
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.